Food and Drug Administration, HHS.
The Food and Drug Administration (FDA) is providing notice of a memorandum of understanding (MOU) between FDA and the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) of the Department of Health and Human Services (DHHS). The purpose of this MOU is to establish a formal collaboration between FDA and NCI regarding the creation of a common standards-based data repository to facilitate the electronic exchange and analysis of data from research studies on investigational drugs in a fully secure manner.
The agreement became effective March 2, 2007.Start Further Info
FOR FURTHER INFORMATION CONTACT:
Randy Levin, Center for Drug Evaluation Research (HF-18), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-7784 e-mail: firstname.lastname@example.org.End Further Info End Preamble Start Supplemental Information
In accordance with 21 CFR 20.108(c), which states that all written agreements and MOUs between FDA and others shall be published in the Federal Register, the agency is publishing notice of this MOU.Start Signature
Dated: April 5, 2007.
Assistant Commissioner for Policy.
BILLING CODE 4160-01-S
[FR Doc. 07-1921 Filed 4-17-07; 8:45 am]
BILLING CODE 4160-01-C